Latest News

Latest News2018-07-31T19:14:53+01:00

Irish prostate medtech ProVerum raises €30m in funding

January 14th, 2022|

Irish medtech company ProVerum has raised €30 million to support its clinical programme as it looks to go to market with its ground-breaking ProVee device in both Europe and the US. The series A funding round was co-led by Gilde Healthcare and Lightstone Ventures, with Atlantic Bridge and other existing investors also participating. ProVerum, which was founded by Ríona Ní Ghriallais and Conor Harkin in 2016 as a spinout from Trinity College Dublin, has developed a novel treatment solution [...]

Sigrid Therapeutics raises funding of $8.4M from US, Irish and Swedish investors for diabetes breakthrough

November 16th, 2021|

STOCKHOLM, Nov. 10, 2021 /PRNewswire/ -- Swedish healthtech startup Sigrid Therapeutics is set to prevent two of the world's biggest health challenges, type 2 diabetes and obesity with its SiPore15® powder. This vision has attracted a number of Sweden's family offices to invest just over $8.4 million in new capital making a total since inception of $17.5 million. "A quarter of the world population is affected with chronic lifestyle diseases which are preventable. That is why we created SiPore15® [...]

Angel investments exceed pre-pandemic levels says HBAN

October 30th, 2021|

Angle investment into Irish start-ups is now higher than at pre-pandemic levels and thriving, according to figures from a business angels network. It says angels invested £7 million in fledgling businesses on the island of Ireland in the first half of this year, which was up 13 per cent when compared to the same pre-pandemic period in 2019. And the HBAN (Halo Business Angel Network), the all-island organisation responsible for [...]

Waterford software company StitcherAds acquired for €55m

October 18th, 2021|

Irish online advertising software company StitcherAds has been acquired in a $64 million (€55million) deal. The buyer is US adtech company Kargo, which is looking to exceed $100 million in revenues this year. The deal was first reported by the Wall Street Journal on Monday. StitcherAds, which earlier this year announced plans to create 40 jobs, is a marketing platform that helps advertisers publish paid ads that drive sales via [...]

AniV8 announces oversubscribed pre-seed funding round

October 4th, 2021|

Funding will accelerate development of wearable monitor to detect osteoarthritis-related pain in companion animals Backed by experienced seed investors including Irrus Investments, Pro-Vet and Stonehaven Incubate Seed financing planned for 2022 to further drive product development and commercialization Investment by Pro-Vet enables for commercialization in China and other Asian countries Delaware, US, 4 October 2021 – AniV8, a leading developer of clinical sensor technology to diagnose and monitor diseases affecting companion [...]

Greentech firm Qualus secures additional £1 Million financing

June 1st, 2021|

With patented polymer Sfere technology, Qualus is helping tanneries around the world reduce water consumption by up to 40% and chemicals by up to 15% LONDON – Qualus, the leading provider of sustainable solutions to the leather industry, has secured £1 million of financing in a round led by Irrus Investments, an Ireland based angel syndicate. Co-investors in the round include CPI Enterprises and angels from Cambridge Capital Group and Harvard Business [...]

Mirai Medical Announces First Patient Enrolled in VECTOR Trial using ePORE® therapy for the Treatment of Inoperable Oesophageal and Gastric Cancer

April 15th, 2021|

Mirai Medical Ltd, a manufacturer of a precision cancer therapy platform , today announced the first procedures in the clinical trial to evaluate ePORE® therapy and EndoVE®, a novel breakthrough technology that can treat gastrointestinal cancers endoscopically in an outpatient setting with minimum hospitalisation for the patient. The first procedure in the VECTOR trial (NCT04649372) was performed this week at Nottingham NHS Trust, United Kingdom in a team led by [...]

Aruna Bio Closes $10.8 Million Common Stock Financing

April 14th, 2021|

ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the closing of a common stock financing totalling $10.8 million. Proceeds from the raise will support the company’s business plan through mid-2022. “This capital will allow us to continue our efforts to deliver important therapeutics to the central nervous [...]

If you are interested in becoming an Investor or seeking investment, then please contact us.

Go to Top